138 related articles for article (PubMed ID: 2022031)
1. Endothelin has biological actions at pathophysiological concentrations.
Lerman A; Hildebrand FL; Aarhus LL; Burnett JC
Circulation; 1991 May; 83(5):1808-14. PubMed ID: 2022031
[TBL] [Abstract][Full Text] [Related]
2. Chronic endothelin-induced pressor and renal actions in conscious dogs do not require altered ANG II formation.
Wilkins FC; Kassab S; Kato T; Mizelle HL; Opgenorth TJ; Granger JP
Am J Physiol; 1995 Feb; 268(2 Pt 2):R395-402. PubMed ID: 7864234
[TBL] [Abstract][Full Text] [Related]
3. Systemic hemodynamics and renal function during long-term pathophysiological increases in circulating endothelin.
Wilkins FC; Alberola A; Mizelle HL; Opgenorth TJ; Granger JP
Am J Physiol; 1995 Feb; 268(2 Pt 2):R375-81. PubMed ID: 7864231
[TBL] [Abstract][Full Text] [Related]
4. Renal and hemodynamic effects of endothelin in anesthetized dogs.
Tsuchiya K; Naruse M; Sanaka T; Naruse K; Zeng ZP; Nitta K; Demura H; Shizume K; Sugino N
Am J Hypertens; 1990 Oct; 3(10):792-5. PubMed ID: 2222945
[TBL] [Abstract][Full Text] [Related]
5. Effects of renal arterial endothelin-1 and endogenous endothelins on regional kidney blood flow and renal antihypertensive mechanisms in anesthetized rabbits.
Weekes SR; Madden AC; Bergström G; Anderson WP; Evans RG
Kidney Blood Press Res; 2000; 23(6):366-75. PubMed ID: 11070416
[TBL] [Abstract][Full Text] [Related]
6. Integrated cardiac, renal, and endocrine actions of endothelin.
Miller WL; Redfield MM; Burnett JC
J Clin Invest; 1989 Jan; 83(1):317-20. PubMed ID: 2642921
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular and endocrine effects of endothelin-1 at pathophysiological and pharmacological plasma concentrations in conscious dogs.
Donckier JE; Hanet C; Berbinschi A; Galanti L; Robert A; Van Mechelen H; Pouleur H; Ketelslegers JM
Circulation; 1991 Dec; 84(6):2476-84. PubMed ID: 1835679
[TBL] [Abstract][Full Text] [Related]
8. Effects of renin-angiotensin system in mediating endothelin-induced renal vasoconstriction: therapeutic implications.
Chan DP; Clavell A; Keiser J; Burnett JC
J Hypertens Suppl; 1994 Jul; 12(4):S43-9. PubMed ID: 7965274
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction.
Lerman A; Sandok EK; Hildebrand FL; Burnett JC
Circulation; 1992 May; 85(5):1894-8. PubMed ID: 1572045
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-mediated cardiorenal hemodynamic and neuroendocrine effects are attenuated by nitroglycerin in vivo.
Miller WL; Cavero PG; Aarhus LL; Heublein DM; Burnett JC
Am J Hypertens; 1993 Feb; 6(2):156-63. PubMed ID: 8385958
[TBL] [Abstract][Full Text] [Related]
11. Endothelin at pathophysiological concentrations mediates coronary vasoconstriction via the endothelin-A receptor.
Cannan CR; Burnett JC; Brandt RR; Lerman A
Circulation; 1995 Dec; 92(11):3312-7. PubMed ID: 7586319
[TBL] [Abstract][Full Text] [Related]
12. Increased endothelin in experimental heart failure.
Margulies KB; Hildebrand FL; Lerman A; Perrella MA; Burnett JC
Circulation; 1990 Dec; 82(6):2226-30. PubMed ID: 2242543
[TBL] [Abstract][Full Text] [Related]
13. Role of endogenous endothelin in normal hemodynamic status of anesthetized dogs.
Teerlink JR; Carteaux JP; Sprecher U; Löffler BM; Clozel M; Clozel JP
Am J Physiol; 1995 Jan; 268(1 Pt 2):H432-40. PubMed ID: 7840293
[TBL] [Abstract][Full Text] [Related]
14. Role of endothelin receptor subtypes in the in vivo regulation of renal function.
Clavell AL; Stingo AJ; Margulies KB; Brandt RR; Burnett JC
Am J Physiol; 1995 Mar; 268(3 Pt 2):F455-60. PubMed ID: 7900845
[TBL] [Abstract][Full Text] [Related]
15. Renal actions of endothelin: interaction with prostacyclin.
Chou SY; Dahhan A; Porush JG
Am J Physiol; 1990 Oct; 259(4 Pt 2):F645-52. PubMed ID: 2221102
[TBL] [Abstract][Full Text] [Related]
16. Biological role for the endothelin-A receptor in aortic cross-clamping.
Stingo AJ; Clavell AL; Aarhus LL; Burnett JC
Hypertension; 1993 Jul; 22(1):62-6. PubMed ID: 8319993
[TBL] [Abstract][Full Text] [Related]
17. Interaction of ANP with endothelin on cardiovascular, renal, and endocrine function.
Ota K; Kimura T; Shoji M; Inoue M; Sato K; Ohta M; Yamamoto T; Tsunoda K; Abe K; Yoshinaga K
Am J Physiol; 1992 Feb; 262(2 Pt 1):E135-41. PubMed ID: 1531732
[TBL] [Abstract][Full Text] [Related]
18. Endothelin in thoracic inferior vena caval constriction model of heart failure.
Underwood RD; Aarhus LL; Heublein DM; Burnett JC
Am J Physiol; 1992 Sep; 263(3 Pt 2):H951-5. PubMed ID: 1415622
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular actions of ET-B activation in vivo and modulation by receptor antagonism.
Rasmussen TE; Jougasaki M; Supaporn T; Hallett JW; Brooks DP; Burnett JC
Am J Physiol; 1998 Jan; 274(1):R131-8. PubMed ID: 9458909
[TBL] [Abstract][Full Text] [Related]
20. Effects of continuous infusion of endothelin-1 in pregnant sheep.
Greenberg SG; Baker RS; Yang D; Clark KE
Hypertension; 1997 Dec; 30(6):1585-90. PubMed ID: 9403587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
